Bosentan Does Not Affect Renal Resistive Index in Scleroderma/Systemic Sclerosis Patients

Bosentan Does Not Affect Renal Resistive Index in Scleroderma/Systemic Sclerosis Patients

Introduction: If properly evaluated, chronic kidney disease can be found in up to 50% of patients with systemic sclerosis (SSc). The renal resistive index (RRI) is a marker of intrarenal vascular resistance and can predict SSc-associated vasculopathy. This study aimed to determine the impact of bose...

Full description

Bibliographic Details
Main Authors: Emma Di Poi, GianLuca Colussi, Martina Bertoni, Ivan Giovannini, Barbara Tolusso, Gian Franco Ferraccioli, Elisa Gremese, Salvatore De Vita, Giulio Romano
Format: Article
Language:English
Published: Karger Publishers 2023-11-01
Series:Kidney & Blood Pressure Research
Subjects:
systemic sclerosis
renal hemodynamics
endothelin
pulse pressure
chronic kidney disease
Online Access:https://beta.karger.com/Article/FullText/534642

Internet

https://beta.karger.com/Article/FullText/534642

Similar Items